WHO publishes its new Essential Medicines List

8 May 2015
who-big

The World Health Organization has published a new edition of its Model List of Essential Medicines, including groundbreaking treatments for hepatitis C and multi-drug resistant tuberculosis.

This will enable public health bodies globally to improve access to innovative medicines with clear clinical benefits. Margaret Chan, director general of the WHO, said: “When new effective medicines emerge to safely treat serious and widespread diseases,  it is vital to  ensure that everyone who needs them can obtain them. Placing them on the WHO Essential Medicines List is a first step in that direction.”

The list is updated every two years by an expert committee, which this year highlighted the urgent need to take action and promote equitable access to several new highly effective medicines, some currently too costly for even high-income countries.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical